11:15 AM EDT, 09/30/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week lower late Monday morning, declining 0.5% to 1,435.36 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company Genfit ( GNFT ) , which rose 6.2% and 5.8% respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and petroleum refiner Equinor ( EQNR ) , which were up 2% and 1.7% respectively.

The decliners from continental Europe were led by medical device maker Edap TMS ( EDAP ) and pharmaceutical company Novo Nordisk ( NVO ) , which dropped 4.3% and 2% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) and accommodations booking site trivago (TRVG), which lost 1.5% and 0.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin ( AMRN ) and biotech firm Trinity Biotech ( TRIB ) , which increased 5.3% and 2.8% respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which rose 1% and 0.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and cruise line operator Carnival (CUK), which fell 4.7% and 3.3% respectively. They were followed by hospitality company InterContinental Hotels Group ( IHG ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which declined 1.9% and 1.5% respectively.

Price: 1.18, Change: +0.07, Percent Change: +6.22